Technology and innovation drive each other

As a new generation of Acute Respiratory Support, the INSPIRA™ ART500 is designed to elevate and stabilize decreasing oxygen saturation levels in minutes without a mechanical ventilator.

Discover INSPIRATM ART500

A novel technology that could potentially bring hope to the 20 million patients each year who end up in intensive care units and are placed on mechanical ventilators.

To overcome the risks and medical complication associated with mechanical ventilator that require intubation and coma, the INSPIRA™ ART500 is designed to treat the patients while they are awake.

The INSPIRA™ ART500 targets to boost oxygen saturation levels to 95% or higher in minutes with small volumes of blood being monitored for the rapid detection of life-threatening medical conditions.

Challenging the foundations of Life Support to eliminate the need for mechanical ventilation treatment.

Market Size

Aiming to Revolutionize the $19 Billion
Mechanical Ventilation Market

 

±20 Millions / Year
on Mechanical Ventilation

Novel Patents

Inspira™ Patent Portfolio
VORTX™ | U.S Granted
Dual Lumen Cannula | U.S Granted
Initiation Module | U.S Granted
Cannula Fixation Device | U.S Filed

News & Events

September 18, 2025

Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed

September 11, 2025

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to [email protected]. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.

    Join Our Newsletter!

    Sign up and be the first to get notified on new updates of Inspira Technologies

      Copyright © 2018-2022 Inspira-Technologies OXY B.H.N. LTD., All rights reserved